Heron Therapeutics Inc
HRTX1.740USD
+0.050+2.96%
交易中 （美东）报价延迟15分钟
265.22M总市值
亏损市盈率 TTM
关于 Heron Therapeutics Inc 公司
Heron Therapeutics, Inc. 是一家商业阶段的生物技术公司。该公司将一系列产品商业化，用于护理急性护理和肿瘤患者。其肿瘤护理产品组合包括 SUSTOL 和 CINVANTI。SUSTOL 用于预防与中度致吐化疗 (MEC) 以及蒽环类和环磷酰胺 (AC) 联合化疗方案相关的急性和延迟性恶心和呕吐。CINVANTI 是阿瑞吡坦的静脉 (IV) 制剂，阿瑞吡坦是一种 P 物质/神经激肽-1 (NK1) 受体拮抗剂。其急性护理产品组合包括 ZYNRELEF 和 APONVIE。HTX- ZYNRELEF 是一种双作用局部麻醉剂，可提供局部麻醉剂布比卡因和低剂量非甾体抗炎药美洛昔康的固定剂量组合。 APONVIE 是一种 NK1 受体拮抗剂的静脉注射剂型，用于治疗术后恶心呕吐 (PONV)。其产品在美国销售。
公司简介
公司代码HRTX
公司名称Heron Therapeutics Inc
上市日期Aug 26, 1987
CEOMr. Craig Alexander Collard
员工数量122
证券类型Ordinary Share
年结日Aug 26
公司地址100 Regency Forest Drive
城市CARY
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编27518
电话18582514400
网址https://www.herontx.com/
公司代码HRTX
上市日期Aug 26, 1987
CEOMr. Craig Alexander Collard
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Craig Alexander Collard
Mr. Craig Alexander Collard
Chief Executive Officer, Director
Chief Executive Officer, Director
420.81K
+3.39%
Ms. Ira Duarte
Ms. Ira Duarte
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
152.52K
+2.61%
Dr. William P. (Bill) Forbes
Dr. William P. (Bill) Forbes
Executive Vice President, Chief Development Officer
Executive Vice President, Chief Development Officer
138.94K
+2.87%
Dr. Sharmila Dissanaike, M.D.
Dr. Sharmila Dissanaike, M.D.
Independent Director
Independent Director
68.45K
-3.44%
Mr. Christian Waage
Mr. Christian Waage
Independent Director
Independent Director
66.18K
+26.70%
Mr. Craig A. Johnson
Mr. Craig A. Johnson
Lead Independent Director
Lead Independent Director
65.82K
-5.73%
Mr. Adam Morgan
Mr. Adam Morgan
Chairman of the Board
Chairman of the Board
32.89K
+19.94%
Mr. Michael Kaseta
Mr. Michael Kaseta
Independent Director
Independent Director
2.37K
-95.76%
Mr. Mark Hensley
Mr. Mark Hensley
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Craig Alexander Collard
Mr. Craig Alexander Collard
Chief Executive Officer, Director
Chief Executive Officer, Director
420.81K
+3.39%
Ms. Ira Duarte
Ms. Ira Duarte
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
152.52K
+2.61%
Dr. William P. (Bill) Forbes
Dr. William P. (Bill) Forbes
Executive Vice President, Chief Development Officer
Executive Vice President, Chief Development Officer
138.94K
+2.87%
Dr. Sharmila Dissanaike, M.D.
Dr. Sharmila Dissanaike, M.D.
Independent Director
Independent Director
68.45K
-3.44%
Mr. Christian Waage
Mr. Christian Waage
Independent Director
Independent Director
66.18K
+26.70%
Mr. Craig A. Johnson
Mr. Craig A. Johnson
Lead Independent Director
Lead Independent Director
65.82K
-5.73%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
业务USD
名称
营收
占比
CINVANTI
25.74M
66.17%
ZYNRELEF
8.04M
20.67%
SUSTOL
2.86M
7.35%
APONVIE
2.26M
5.81%
地区USD
名称
营收
占比
United States
38.90M
100.00%
业务
地区
业务USD
名称
营收
占比
CINVANTI
25.74M
66.17%
ZYNRELEF
8.04M
20.67%
SUSTOL
2.86M
7.35%
APONVIE
2.26M
5.81%
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
Rubric Capital Management LP
17.51%
The Vanguard Group, Inc.
5.39%
Adage Capital Management, L.P.
5.15%
BlackRock Institutional Trust Company, N.A.
5.11%
Velan Capital Investment Management LP
4.58%
Other
62.26%
持股股东
持股股东
占比
Rubric Capital Management LP
17.51%
The Vanguard Group, Inc.
5.39%
Adage Capital Management, L.P.
5.15%
BlackRock Institutional Trust Company, N.A.
5.11%
Velan Capital Investment Management LP
4.58%
Other
62.26%
股东类型
持股股东
占比
Hedge Fund
35.76%
Investment Advisor
24.53%
Investment Advisor/Hedge Fund
16.56%
Research Firm
3.08%
Private Equity
1.45%
Pension Fund
1.17%
Individual Investor
0.70%
Bank and Trust
0.14%
Venture Capital
0.06%
Other
16.54%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
350
127.68M
83.69%
-21.02M
2025Q1
384
126.94M
83.22%
-22.20M
2024Q4
390
118.52M
78.10%
-45.51M
2024Q3
400
125.21M
82.85%
-42.71M
2024Q2
402
132.96M
88.55%
-36.75M
2024Q1
402
122.65M
81.87%
-45.18M
2023Q4
413
115.58M
77.36%
-37.11M
2023Q3
417
122.12M
87.17%
-25.94M
2023Q2
428
102.54M
85.75%
-39.37M
2023Q1
447
111.46M
93.56%
-41.46M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Rubric Capital Management LP
26.71M
17.51%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
8.23M
5.39%
+67.98K
+0.83%
Mar 31, 2025
Adage Capital Management, L.P.
7.85M
5.15%
-648.00K
-7.62%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
7.79M
5.11%
-114.84K
-1.45%
Mar 31, 2025
Velan Capital Investment Management LP
6.99M
4.58%
--
--
Apr 21, 2025
Palisade Capital Management, LLC
5.29M
3.47%
+1.36M
+34.65%
Mar 31, 2025
Point72 Asset Management, L.P.
4.78M
3.13%
+1.70M
+55.27%
Mar 31, 2025
Tejara Capital Ltd.
4.58M
3%
-84.14K
-1.80%
Mar 31, 2025
State Street Global Advisors (US)
3.25M
2.13%
+107.71K
+3.42%
Mar 31, 2025
Geode Capital Management, L.L.C.
3.11M
2.04%
+98.40K
+3.26%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Invesco NASDAQ Future Gen 200 ETF
0.5%
iShares Micro-Cap ETF
0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
Principal U.S. Small-Cap ETF
0.02%
iShares Russell 2000 Value ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
查看更多
Invesco NASDAQ Future Gen 200 ETF
占比0.5%
iShares Micro-Cap ETF
占比0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.02%
Principal U.S. Small-Cap ETF
占比0.02%
iShares Russell 2000 Value ETF
占比0.02%
Invesco RAFI US 1500 Small-Mid ETF
占比0.01%
Schwab U.S. Small-Cap ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
Global X Russell 2000 ETF
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
